COMMUNIQUÉS West-GlobeNewswire
-
Bavarian Nordic Awarded Multi-Year Vaccine Contract by UK Government
02/11/2026 -
HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
02/11/2026 -
Mesoblast Board Changes
02/11/2026 -
Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
01/11/2026 -
TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
01/11/2026 -
Chaka Khan Opens Chaka's Plantbaed Café in Serenbe, Georgia, November 1
01/11/2026 -
Dr. Myung Ju Lee Presents Hybrid Deep Plane Facelift Technique for Nasolabial Fold Correction at ISAPS 2026
31/10/2026 -
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
30/10/2026 -
Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026
30/10/2026 -
Nathan Fielder Meets Ryan ElHosseiny: The Science Behind “The Strip Club” and “Who’s on First” in You Can See Everything
30/10/2026 -
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/10/2026 -
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
30/10/2026 -
SRX Global Provides Update on Balance Sheet and Share Buyback
30/10/2026 -
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
30/10/2026 -
TME Pharma Publishes Its Semi Annual Results and Half-Year Report
30/10/2026 -
TME Pharma publie ses résultats semestriels et son rapport semestriel
30/10/2026 -
Halloween Peptide Sale 2026: Kylo Peptides Announces $1 Research Vial Sale With Orders of $200 or More
30/10/2026 -
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
30/10/2026 -
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
30/10/2026
Pages